Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • DerSeb
    Member
    • Oct 2009
    • 44

    #1

    Large scale cuffdiff analysis

    Hi all,

    already my second threat these days, but I have another question regarding analyzing RNA-seq data with the cufflinks package.

    We have used cuffdiff and other approaches to look for differences in promoter usage etc. We find that the cuffdiff results have the best accuracy so far, when we compare our results with that of other experiments in the same setting.

    However, as a next step we have to do an extensive extra amount of tests. We want to run ~ 600 comparisons with ~15 vs 15 samples each. Each sample has about 140 million 2x 100bp reads. You can imagine that this is not really possible using the traditional approach.

    My question: Is it possible to

    a) once estimate the FPKM values of all samples and then do the cuffdiff tests with these as input (not the raw reads).

    or

    b) is it ok to extract the reads from genes of interest and test only those? I imagine there might be a problem normalizing these reads when the whole dataset is not there.

    Basically, we have 30 samples and want to test them in 600 different distributions.

    Thanks,
    Seb
  • weasteam
    Member
    • Dec 2008
    • 26

    #2
    have same problem here,

    still wondering why cuffdiff does not utilize multiple threads after mapping...too slow...

    I tried to split the gtf files, and it was not working well.

    Comment

    • jjjscuedu
      Member
      • Mar 2012
      • 35

      #3
      Does anyone have a good solution for this problem?

      I am also confuse why cuffdiff does not utilize multiple threads after mapping. Too slow to large scale date set.

      Comment

      Latest Articles

      Collapse

      • SEQadmin2
        Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
        by SEQadmin2



        Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

        Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
        ...
        10-14-2026, 09:55 AM
      • SEQadmin2
        New Genomics Technologies Take Aim at Long-Standing Limits
        by SEQadmin2


        Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

        We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
        ...
        09-28-2026, 10:25 AM

      ad_right_rmr

      Collapse

      News

      Collapse

      Topics Statistics Last Post
      Started by SEQadmin2, Yesterday, 11:13 AM
      0 responses
      16 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, Yesterday, 10:48 AM
      0 responses
      18 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 10-15-2026, 10:52 AM
      0 responses
      35 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 10-14-2026, 05:39 AM
      0 responses
      42 views
      0 reactions
      Last Post SEQadmin2  
      Working...